Roth Capital Brokers Increase Earnings Estimates for MBRX
Moleculin Biotech, Inc. (NASDAQ:MBRX – Free Report) – Analysts at Roth Capital upped their Q2 2025 earnings per share estimates for Moleculin Biotech in a report released on Wednesday, May 14th. Roth Capital analyst J. Aschoff now anticipates that the company will post earnings of ($0.42) per share for the quarter, up from their prior […]
Moleculin Biotech, Inc. (NASDAQ:MBRX – Free Report) – Analysts at Roth Capital upped their Q2 2025 earnings per share estimates for Moleculin Biotech in a report released on Wednesday, May 14th. Roth Capital analyst J. Aschoff now anticipates that the company will post earnings of ($0.42) per share for the quarter, up from their prior […]
